The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALLOGENE THERAPEUTICS INC | COM | 019770106 | BBG00KHRRDY2 | 2,493,218 | 396,378 | SH | SOLE | 396,378 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | BBG001SD42R0 | 11,667,110 | 9,642,240 | SH | SOLE | 9,642,240 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | BBG007KGRPZ3 | 15,513,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
BURNING ROCK BIOTECH LTD | SPONSORED ADS | 12233L107 | BBG00V1JWFQ1 | 16,631,057 | 7,391,581 | SH | SOLE | 7,391,581 | 0 | 0 | ||
CABALETTA BIO INC | COM | 12674W109 | BBG00MJ3BKX1 | 1,530,746 | 165,486 | SH | SOLE | 165,486 | 0 | 0 | ||
CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | BBG001SDL5X7 | 47,730 | 90,484 | SH | SOLE | 90,484 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | BBG001S7QN20 | 71,552,232 | 1,605,390 | SH | SOLE | 1,605,390 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | BBG01081FC68 | 2,275,171 | 733,926 | SH | SOLE | 733,926 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | BBG007DHY102 | 9,179,206 | 794,049 | SH | SOLE | 794,049 | 0 | 0 | ||
CONCERT PHARMACEUTICALS INC | COM | 206022105 | BBG001V2MTD6 | 25,814,838 | 4,420,349 | SH | SOLE | 4,420,349 | 0 | 0 | ||
CONNECT BIOPHARMA HLDGS LTD | ADS | 207523101 | BBG00ZGYNJZ5 | 641,867 | 739,649 | SH | SOLE | 739,649 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | BBG00MVWLMC1 | 3,844,253 | 1,771,545 | SH | SOLE | 1,771,545 | 0 | 0 | ||
GSK PLC | SPONSORED ADR | 37733W204 | BBG001SD6SM6 | 17,627,735 | 501,643 | SH | SOLE | 501,643 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | BBG001T9M4T2 | 125,180,000 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
LIQUIDIA CORPORATION | COM NEW | 53635D202 | BBG001V0GFD7 | 11,165,597 | 1,752,841 | SH | SOLE | 1,752,841 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | BBG001SF6HK7 | 8,661,369 | 191,158 | SH | SOLE | 191,158 | 0 | 0 | ||
NATERA INC | COM | 632307104 | BBG001V0FSF8 | 104,570,825 | 2,603,207 | SH | SOLE | 2,603,207 | 0 | 0 | ||
NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | BBG005Y0QF99 | 61,469 | 120,764 | SH | SOLE | 120,764 | 0 | 0 | ||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | BBG00T5JMRV1 | 4,961,823 | 2,025,234 | SH | SOLE | 2,025,234 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | BBG002B63KP4 | 5,683,259 | 520,922 | SH | SOLE | 520,922 | 0 | 0 | ||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | BBG001TFZB81 | 2,375,606 | 561,609 | SH | SOLE | 561,609 | 0 | 0 | ||
SERES THERAPEUTICS INC | COM | 81750R102 | BBG0099X6868 | 4,349,307 | 776,662 | SH | SOLE | 776,662 | 0 | 0 | ||
SUTRO BIOPHARMA INC | COM | 869367102 | BBG001T94MP6 | 3,268,716 | 404,544 | SH | SOLE | 404,544 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | BBG001T92272 | 65,182,209 | 2,561,187 | SH | SOLE | 2,561,187 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | BBG001SL72C5 | 8,792,622 | 418,099 | SH | SOLE | 418,099 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | BBG001S8RV10 | 27,809,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | BBG009PHHPP4 | 33,729,996 | 703,441 | SH | SOLE | 703,441 | 0 | 0 | ||
VERA THERAPEUTICS INC | CL A | 92337R101 | BBG00Q72WYH2 | 27,266,046 | 1,409,098 | SH | SOLE | 1,409,098 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | BBG002H24301 | 30,223,499 | 1,034,697 | SH | SOLE | 1,034,697 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | BBG00B642V63 | 8,667,274 | 1,238,182 | SH | SOLE | 1,238,182 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | BBG002VBMLS5 | 1,139,014 | 28,887 | SH | SOLE | 28,887 | 0 | 0 |